Form 4: Select Medical Holdings Executive Chairman Receives Stock Grant

Sentiment:

SEC Filing Form 4


Robert A. Ortenzio, Executive Chairman of Select Medical Holdings, reports the acquisition of 230,000 shares of common stock through a restricted stock grant.

Summary

  • Robert A. Ortenzio, the Executive Chairman of Select Medical Holdings Corp, filed a Form 4 on May 1, 2024, reporting a transaction that occurred on April 30, 2024.
  • The transaction involved the acquisition of 230,000 shares of Select Medical Holdings common stock through a grant.
  • The shares were acquired directly and the price was $0.
  • Following the transaction, Ortenzio directly owns 6,919,668 shares of common stock.
  • Ortenzio also indirectly owns shares through various trusts.
  • The restricted stock will vest in equal annual installments over three years.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by the Executive Chairman suggests confidence, but it's a routine transaction.

Positives

  • The acquisition of shares by the Executive Chairman could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The restricted stock will vest in equal annual installments over three years, suggesting a long-term commitment from the executive.

Industry Context

Stock grants are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.

Stakeholder Impact

  • The stock grant could positively influence shareholder sentiment.

Key Dates

DateDescription
04/30/2024Date of the stock grant transaction.
05/01/2024Date the Form 4 was filed.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.